GlassScriptPhysician profile
Ian K Mcleod
NPI 1255322145
$1,781.28
in general payments reported to CMS, 2019-2025
17 companies · $76.55 in 2025
The $76.55 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $345 · 2021: $354 · 2022: $177 · 2023: $67.79 · 2024: $141 · 2025: $76.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $476.37 | 2019-2022 | |
| Intersect Ent, INC. | $210.34 | 2019-2021 | |
| Integra Lifesciences Corporation | $207.58 | 2019-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Acclarent, INC | $181.14 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $158.34 | 2020-2024 | Dupixent |
| Glaxosmithkline, LLC. | $139.36 | 2021-2023 | Nucala |
| Alk-Abello, INC | $107.28 | 2019-2022 | |
| Aerin Medical INC. | $54.51 | 2020-2025 | |
| Optinose US, INC. | $49.85 | 2022 | |
| Smith+Nephew, INC. | $35.17 | 2019-2020 | |
| Genzyme Corporation | $32.93 | 2024 | |
| Organogenesis INC. | $31.83 | 2021 | |
| Axsome Therapeutics, INC. | $22.13 | 2025 | Sunosi |
| Acera Surgical, INC. | $20.56 | 2020 | |
| Sanofi-Aventis U.S. LLC | $20.50 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $17.28 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Mcleod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.